Aspirin; Dipyridamole Patent Expiration
Aspirin; Dipyridamole is Used for reducing the risk of stroke in patients with previous transient ischemic attacks or ischemic strokes caused by thrombosis. It was first introduced by Boehringer Ingelheim Pharmaceuticals Inc
Aspirin; Dipyridamole Patents
Given below is the list of patents protecting Aspirin; Dipyridamole, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Aggrenox | US6015577 | Pharmaceutical compositions containing dipyridamole or mopidamol and acetylsalicylic acid or the physiologically acceptable salts thereof, processes for preparing them and their use in treating clot formation |
Jan 18, 2017
(Expired) | Boehringer Ingelheim |
Aspirin; Dipyridamole's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List